Biopharmaceutical benchmarks 2014
- 9 October 2014
- journal article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 32 (10), 992-1000
- https://doi.org/10.1038/nbt.3040
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- The special case of gene therapy pricingNature Biotechnology, 2014
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMappNature, 2014
- Antibody–drug conjugates: current status and future directionsDrug Discovery Today, 2013
- Approval of the first biosimilar antibodies in EuropemAbs, 2013
- Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cellsAdvanced Drug Delivery Reviews, 2013
- Plant-Based Protein BiomanufacturingGenetic Engineering & Biotechnology News, 2013
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaquesProceedings of the National Academy of Sciences of the United States of America, 2012
- Biopharmaceutical benchmarks 2010Nature Biotechnology, 2010
- Single-Batch Production of Recombinant Human Polyclonal AntibodiesMolecular Biotechnology, 2010
- Biopharmaceutical benchmarks 2006Nature Biotechnology, 2006